E&G Advisors’s iShares Biotechnology ETF IBB Stock Holding History

E&G Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,125	Closed	-$465K	–	98
2015 Q4	$465K	Sell	4,125 -300	-7%	-$32.6K	0.28%	66
2015 Q3	$447K	Buy	4,425 +600	+16%	+$72K	0.28%	67
2015 Q2	$470K	Sell	3,825 -2,100	-35%	-$251K	0.27%	69
2015 Q1	$678K	Buy	5,925 +195	+3%	+$21.5K	0.4%	62
2014 Q4	$579K	Sell	5,730 -390	-6%	-$37.9K	0.38%	64
2014 Q3	$558K	Buy	+6,120	New	+$537K	0.36%	73

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

E&G Advisors's IBB Position: Q1 2016 in Review

E&G Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 4,125 shares — an estimated $465K sold.

E&G Advisors first reported a position in IBB in Q3 2014 and held it in 6 quarters. The position peaked at $678K in Q1 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

E&G Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
E&G Advisors sold 4,125 iShares Biotechnology ETF shares in Q1 2016, an estimated $465K.
E&G Advisors first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 6 quarters.
E&G Advisors's iShares Biotechnology ETF position peaked at $678K in Q1 2015.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on E&G Advisors's 13F filing for Q1 2016, filed 12 Apr 2016.